Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence

(2020) Ming Te Yeh et al.   Cell Host & Microbe

Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020

(2020) Mary M. Alleman et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization

(2020) Jennifer L. Konopka-Anstadt et al.   npj Vaccines

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania

(2020) Ananda S Bandyopadhyay et al.   JOURNAL OF INFECTIOUS DISEASES

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

(2019) Pierre Van Damme et al.   LANCET

Update on Vaccine-Derived Polioviruses — Worldwide, January 2015–May 2016

(2016) Jaume Jorba et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global Burden

(2014) L. R. Platt et al.   JOURNAL OF INFECTIOUS DISEASES